Literature DB >> 28163138

Intrathecal or intraventricular administration of colistin, vancomycin and amikacin for central nervous system infections in neurosurgical patients in an intensive care unit.

Angeliki Tsimogianni1, Panagiotis Alexandropoulos2, Vasiliki Chantziara2, Aimilia Vassi2, Georgia Micha2, Fotini Lagiou2, Efrosini Chinou3, Georgios Michaloudis2, Serafeim Georgiou2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28163138     DOI： 10.1016/j.ijantimicag.2017.01.002

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN： 0924-8579            Impact factor:   5.283


× No keyword cloud information.
  4 in total

1.  Local complications of adjunct intrathecal antibiotics for nosocomial meningitis associated with gram-negative pathogens: a meta-analysis.

Authors:  Alexandros G Brotis; Isaac Churis; Marios Karvouniaris
Journal:  Neurosurg Rev       Date:  2019-12-24       Impact factor: 3.042

Review 2.  Amikacin: Uses, Resistance, and Prospects for Inhibition.

Authors:  Maria S Ramirez; Marcelo E Tolmasky
Journal:  Molecules       Date:  2017-12-19       Impact factor: 4.411

3.  Spinal arachnoiditis followed by intrathecal tigecycline therapy for central nervous system infection by extremely drug-resistant Acinetobacter baumannii.

Authors:  Liang-Ming Li; Wen-Jian Zheng; Shang-Wen Shi
Journal:  J Int Med Res       Date:  2020-07       Impact factor: 1.671

4.  Two Cases Report of Intrathecal Tigecycline Therapy for Intracranial Infection with Acinetobacter baumannii and Review of Literatures.

Authors:  Guanlin Huang; Wentao Lai; Daxing Wu; Qianliang Huang; Qi Zhong; Xinyun Ye
Journal:  Infect Drug Resist       Date:  2022-04-26       Impact factor: 4.177
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.